Cargando…
[(18)F]FET PET is a useful tool for treatment evaluation and prognosis prediction of anti-angiogenic drug in an orthotopic glioblastoma mouse model
O-2-(18)F-fluoroethyl-l-tyrosine ([(18)F]FET) has been widely used for glioblastomas (GBM) in clinical practice, although evaluation of its applicability in non-clinical research is still lacking. The objective of this study was to examine the value of [(18)F]FET for treatment evaluation and prognos...
Autores principales: | Kim, Ok-Sun, Park, Jang Woo, Lee, Eun Sang, Yoo, Ran Ji, Kim, Won-Il, Lee, Kyo Chul, Shim, Jae Hoon, Chung, Hye Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for Laboratory Animal Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333614/ https://www.ncbi.nlm.nih.gov/pubmed/30671112 http://dx.doi.org/10.5625/lar.2018.34.4.248 |
Ejemplares similares
-
The Use of Longitudinal (18)F-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts
por: Nedergaard, Mette K., et al.
Publicado: (2014) -
Glioblastoma PET/MRI: kinetic investigation of [(18)F]rhPSMA-7.3, [(18)F]FET and [(18)F]fluciclovine in an orthotopic mouse model of cancer
por: Lindemann, Marcel, et al.
Publicado: (2022) -
(18)F-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma
por: Nedergaard, Mette Kjoelhede, et al.
Publicado: (2015) -
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06
por: Barry, Nathaniel, et al.
Publicado: (2023) -
TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic (18)F-FET PET?
por: Unterrainer, Marcus, et al.
Publicado: (2021)